Reported about 7 hours ago
Shares of Solventum surged after announcing a $4.1 billion sale of its filtration and purification business to Thermo Fisher Scientific, aimed at transforming the company following its spinoff from 3M last year. CEO Bryan Hanson stated that proceeds will be used to reduce debt, while the deal enhances Thermo Fisher's biologic drug manufacturing capabilities. Solventum is expected to release its fourth-quarter earnings soon, and its stock has risen over 20% in the past year.
Source: YAHOO